https://doi.org/10.4081/scs.2011.e17

Stem cell therapy for peripheral arterial disease: a review of clinical trials

Vol. 1 No. 1 (2011)
Submitted: 20 August 2011
Accepted: 10 October 2011
Published: 15 November 2011
stem cell, peripheral arterial disease.
Abstract Views: 632
PDF: 337
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Sharven Taghavi
Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Jason M. Duran
Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Jon C. George
jcgeorgemd@hotmail.com
Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Stem cells have demonstrated significant potential for regeneration in peripheral arterial disease in both animal and human studies. While results of clinical trials have been variable, they have clearly displayed benefit for patients with critical limb ischemia and peripheral arterial disease. Because many of these patients are not eligible for revascularization procedures, there is urgent need for novel therapies. A summary of all clinical trials using stem cell therapy in peripheral arterial disease is described herein with the pertinent findings from each study.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Taghavi, S., Duran, J. M., & George, J. C. (2011). Stem cell therapy for peripheral arterial disease: a review of clinical trials. Stem Cell Studies, 1(1), e17. https://doi.org/10.4081/scs.2011.e17

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.